Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Colorectal Cancer

Breast Cancer

Gastrointestinal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Colorectal Cancer

ATOMIC Looks at Immunotherapy in Early-Stage dMMR Colon Cancer

Investigators are seeking to determine whether immunotherapy that has been effective in metastatic colon cancers with deficient DNA mismatch repair can be applied to earlier-stage disease, specifically, nonmetastatic stage III colon cancer.
Read More >>

FDA Approves CRC Screening Test for Younger, At-Risk Individuals

Top GI Oncologists Share Excitement on 16th Annual ISGIO Conference

Subset of BRAF non-V600-Mutant mCRC Is Potentially More Sensitive to Anti-EGFR Therapy

Shorter Adjuvant Oxaliplatin-Based Therapy Less Effective in High-Risk Stage II CRC

Frontline Nivolumab/Ipilimumab Combo Shows Robust Activity in MSI-H/dMMR mCRC

View More Stories >>

View Conference Coverage

2019 Lynn Sage Breast Cancer Symposium

2019 ESMO Congress

17th International Myeloma Workshop

2019 Society of Hematologic Oncology Annual Meeting

2019 World Conference on Lung Cancer

Dr. Bekaii-Saab on Safety Profile of Tucatinib/Trastuzumab in HER2-Amplified mCRC

Next Steps for Immunoscore in Oncology

Dr. Bekaii-Saab on the Rationale to Evaluate Atezolizumab/Bevacizumab in MSS mCRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Directions in I/O Therapy for mCRC

Immunotherapy in CRC

New Therapy Options for BRAF-Mutated mCRC

Management of Colorectal Cancer Metastases

TRIBE-2: FOLFOX or FOLFIRI With Bevacizumab in mCRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Novel Therapies for BRAF+ Colorectal Cancer

Treating BRAF+ Colorectal Cancer

Targeting BRAF and MEK in Colorectal Cancer

Ongoing Treatment & Approach Advancements in mCRC

Combination Therapy Updates from ASCO 2019

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Treatment Goals in Refractory mCRC

$Treatment Goals in Refractory mCRC$
Tanios Bekaii-Saab, MD, FACP, Andrea Cercek, MD, and Zev A. Wainberg, MD, provide insight to the treatment goals for patients with refractory metastatic colorectal cancer.

View Now

Therapeutic Strategies in Metastatic Colorectal Cancer

Recent advances in the treatment of metastatic colorectal cancer (mCRC) have improved survival. However, many questions remain. Led by John L. Marshall, MD, panelists Tanios Bekaii-Saab, MD; Johanna Bendell, MD; Richard Kim, MD; and Charles S. Fuchs, MD, MPH, discuss strategies and approaches to managing mCRC, including the latest research and how it may influence clinical practice.

View Now

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approval in Myeloma, Label Update in HER2+ Breast Cancer, Breakthrough Status in Prostate Cancer, and More